Search

Displaying results 7111 - 7120 of 8974 in total
  1. Drug

    HM15912

    go.drugbank.com/drugs/DB18266
    Investigational

    HM15912 is a human glucagon-like peptide-2 analogue linked to a human immunoglobulin Fc fragment.

  2. Drug

    5-Methoxy-N,N-diisopropyltryptamine

    go.drugbank.com/drugs/DB01441
    ExperimentalIllicit

    This substance is abused for its hallucinogenic effects.

    Categories: Heterocyclic Compounds with 4 or More Rings
  3. Target

    Forkhead box protein M1

    go.drugbank.com/bio_entities/BE0014280
    TargetHumans

    Transcription factor regulating the expression of cell cycle genes essential for DNA replication and mitosis (PubMed:19160488, PubMed:20360045).

    Synonyms: HNF-3/fork-head homolog 11
  4. Drug

    Phloroglucinol

    go.drugbank.com/drugs/DB12944
    Investigational

    Phloroglucinol has been used in trials studying the diagnostic of Colonoscopy.

    Categories: Drugs for Functional Gastrointestinal Disorders, Compounds used in a research, industrial, or household setting
  5. Drug

    5-(5-(4-(5-hydro-4-methyl-2-oxazolyl)phenoxy)pentyl)-3-methyl isoxazole

    go.drugbank.com/drugs/DB08724
    Experimental

    This compound belongs to the phenol ethers. These are aromatic compounds containing an ether group substituted with a benzene ring. This medication is known to target genome polyprotein.

  6. Drug

    DNB-001

    go.drugbank.com/drugs/DB05757
    Investigational

    DNB-001 is a first-in-class oral therapy with dual mechanism of action, which is initially being developed for the treatment of glaucoma.

  7. Drug

    m-Chlorophenylpiperazine

    go.drugbank.com/drugs/DB12110
    Investigational

    m-Chlorophenylpiperazine has been used in trials studying the treatment of Alcoholism.

    Categories: Serotonergic Drugs Shown to Increase Risk of Serotonin Syndrome
  8. Drug

    Amithiozone

    go.drugbank.com/drugs/DB12829
    Investigational

    Amithiozone has been used in trials studying the treatment of Mycobacterium Avium-intracellulare Infection.

    Categories: Antiinfectives for Systemic Use, Drugs for Treatment of Tuberculosis
  9. Drug

    Arzoxifene

    go.drugbank.com/drugs/DB06249
    ApprovedWithdrawn

  10. Drug

    XAV-19

    go.drugbank.com/drugs/DB15895
    Investigational

    Xenothera has partnered with LFB, a pharmaceutical company, to develop XAV-19, and with Nantes University Hospital to test the treatment in patients[L16553,L16558]. … As of July, 2020, the company is conducting a Phase 2 randomized clinical trial to define dosing safety and efficacy of XAV-19 (NCT04453384).